Navigating Due Diligence in Pharmaceutical CRO Acquisitions: Key Challenges and Opportunities
In the highly competitive pharmaceutical services sector, avid bidding for prominent businesses have observed an exponential acceleration as new players and investors are showing everyday interest. This surge in investors, who previously didn’t focus much on the pharma sector, has necessitated an urgent understanding of central considerations for due diligence. These considerations significantly influence risk…